VERIFIEDET Finance·2 Oct 2026negative

Maharashtra FDA cancels Cipla's Pune warehouse licences over Reactin Plus packaging claims

AI Summary

·Maharashtra FDA has cancelled Cipla Pharma's distribution licenses for its Pune warehouse.
·The cancellation is due to violations including misbranding and unsafe storage of Reactin Plus Tablets.
·Expired medicines were found to be stored incorrectly without proper documentation.